H7N9 monovalent vaccine (Instituto Butantan)

H7N9单价疫苗（Instituto Butantan）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameH7N9 monovalent vaccine (Instituto Butantan)
Drug Alias Namefragmented inactivated monovalent H7N9 influenza vaccine
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Univalent vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesInstituto Butantan
China Registration ClassN/A

Develop Information

Active CompaniesInstituto Butantan
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A